|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
35.180 +0.800 (+2.327%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 596,055 | 29.275% | 1,065,477 | 851,954 | 752,836 | 585,883 |
| Cost of Sales | (231,676) | 21.670% | (428,690) | (314,292) | (314,766) | (253,397) |
| Gross Profit | 364,379 | 34.626% | 636,787 | 537,662 | 438,070 | 332,486 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (3,699) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (585) | (395) | 0 | 0 | |
| Profit / (Loss) before Taxation | 144,683 | 19.863% | 258,322 | 213,384 | 175,128 | 144,468 | |
| Taxation | (19,014) | 4.067% | (25,648) | (23,335) | (21,900) | (10,635) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (15,345) | 292.656% | (13,888) | 1,865 | 3,229 | (2,120) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 110,324 | 11.972% | 218,786 | 191,914 | 156,457 | 131,713 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (9,700) | 259.926% | 554 | (6,678) | (8,637) | (12,590) |
| Depreciation & Amortisation | 58,501 | 31.682% | 104,226 | 79,864 | 47,554 | 37,077 |
| Directors' Emoluments | -- | -- | 10,461 | 9,098 | 9,332 | 6,916 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 54.000 | -5.263% | 126.000 | 110.000 | 92.000 | 79.000 |
| DPS (cts) | 0.000 | -- | 23.000 | 0.000 | 27.000 | 24.000 |
| Dividend Payout Ratio (%) | -- | -- | 18.254% | -- | 29.348% | 30.380% |
| Cash flow per share ($) | -- | -- | 2.119 | 1.371 | 1.074 | 1.087 |
| NBV per share ($) | 13.048 | -- | 11.337 | 10.081 | 9.645 | 9.000 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 110,324 |
| %Change | 11.972% |
| EPS / (LPS) | RMB 0.540 |
| NBV Per Share (¥) | RMB 13.048 |